![]() |
市场调查报告书
商品编码
1784620
2021-2031年北美雷射辅助耳鼻喉手术市场报告(范围、细分、动态和竞争分析)North America Laser-Assisted ENT Surgery Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
北美雷射辅助耳鼻喉手术市场规模预计将从 2023 年的 1,20,527.14 千美元增至 2031 年的 2,45,109.60 千美元。预计 2023 年至 2031 年期间该市场的复合年增长率为 9.3%。
执行摘要和北美雷射辅助耳鼻喉手术市场分析:
慢性鼻窦炎等耳鼻喉疾病的盛行率不断上升,推动了加拿大对有效治疗方案的需求。例如,据加拿大家庭医生称,鼻窦炎是一种常见疾病,大约每8个加拿大成年人中就有1人患有此病。人口老化和人们对耳鼻喉健康问题的认识不断提高,有利于加拿大雷射辅助耳鼻喉手术市场的发展。
北美雷射辅助耳鼻喉手术市场細項分析:
有助于得出雷射辅助耳鼻喉手术市场分析的关键部分是雷射类型、手术类型和最终用户。
根据雷射类型,雷射辅助耳鼻喉手术市场细分为二氧化碳雷射、Nd:YAG雷射、二极体雷射、蓝光雷射、KTP雷射、氩雷射和其他雷射类型。二氧化碳雷射在2023年占据了最大的市场份额。
就手术类型而言,雷射辅助耳鼻喉手术市场分为雷射喉部手术、雷射内视镜鼻窦手术(较少)、雷射辅助悬雍垂腭咽成形术 (LAUP)、雷射辅助镫骨切开术、雷射辅助扁桃体切除术和腺样体切除术、雷射鼻甲缩小术、经口雷射显微手术 (TLM)、鼻腔手术和其他手术类型。 2023 年,雷射辅助扁桃体切除术和腺样体切除术占据了最大的市场份额。
根据最终用户,雷射辅助耳鼻喉手术市场可分为医院和专科诊所、医生办公室和其他最终用户。医院和专科诊所在2023年占据了最大的市场。
北美雷射辅助耳鼻喉手术市场展望
慢性鼻窦炎、睡眠呼吸中止症、听力损失以及各种头颈部肿瘤等疾病日益普遍,需要先进的外科手术介入。雷射辅助手术因其微创特性,提供了一种极具吸引力的解决方案,这也迎合了越来越多的患者对快速恢復和术后不适感较少的手术的偏好。根据2024年发表在《鼻科学》杂誌上的一篇文章,慢性鼻窦炎的盛行率为5%-12%,其中20%的患者患有鼻息肉。
随着全球人口老化,对耳鼻喉疾病有效创新治疗方案的需求也随之激增。此外,环境因素进一步加剧了耳鼻喉相关疾病的发生率。根据美国国家老龄委员会的数据,听力损失影响约 6,070 万 12 岁及以上的美国人。约 15.5%(4,410 万)的 20 岁及以上的美国成年人患有听力损失。此外,耳鼻喉疾病盛行率的不断上升也伴随着人们对早期诊断和治疗重要性的认识的不断提高。随着患者对自己的健康选择比以往任何时候都更加了解,他们更愿意寻求先进的治疗方法,从而从根本上重塑了耳鼻喉科治疗的格局。诊断工具的技术进步促进了耳鼻喉疾病的早期发现,进一步推动了这一趋势。因此,一旦患者被诊断出来,需要手术介入的可能性就会增加,从而推动了雷射辅助手术的数量。
北美雷射辅助耳鼻喉手术市场国家洞察
按国家划分,北美雷射辅助耳鼻喉手术市场包括美国、加拿大和墨西哥。美国在2023年占最大份额。
西尔维斯特综合癌症中心是美国第一家使用 445 nm 蓝色雷射治疗早期声门癌(最常见的喉癌类型)的医院。美国约有 2,000 名耳科医生。他们中的许多人使用 532 nm 雷射系统进行镫骨切除术和镫骨切开术,以矫正某些类型的听力损失。在美国,几种经 FDA 批准的耳鼻喉雷射设备,特别是二氧化碳雷射设备,因其精确度和对周围组织的热损伤最小而广泛用于腺样体切除术和喉部手术等手术。此外,Nd:YAG 雷射系统是二极体雷射,通常用于治疗鼻塞等疾病和进行雷射辅助悬雍垂腭咽成形术。美国食品药物管理局也批准了 BIOLASE 的 EPIC 10 软组织雷射用于耳鼻喉外科手术。随着越来越多的医疗机构采用FDA核准的雷射器,患者的復原时间可望缩短,手术精准度也将提高,进而改善治疗效果。 FDA对这些设备的批准至关重要,它能够确保这些设备符合严格的安全性和有效性标准,并增强医疗服务提供者和患者的信心。
北美雷射辅助耳鼻喉手术市场公司概况
市场上的一些主要参与者包括 biolitec AG (Biolitec)、Iridex Corporation、Medency、Dimed Laser Technology Co., Ltd.、intros Medical Laser GmbH、ARC Laser GmbH、LightScalpel、GIGAAMEDICAL、INTERmedic ARFRAN、Limmer Laser GmbH、Qolight这些参与者正在采用扩张、产品创新和併购等各种策略,为消费者提供创新产品并增加市场份额。
北美雷射辅助耳鼻喉手术市场研究方法:
本报告中的资料收集和分析遵循了以下方法:
二手资料研究:研究流程始于全面的二手资料研究,利用内部和外部资源收集每个市场的定性和定量资料。常用的二手资料研究来源包括但不限于:
公司网站、年度报告、财务报表、经纪商分析和投资者介绍。行业期刊及其他相关出版品。政府文件、统计资料库和市场报告。针对在市场运营的公司的新闻文章、新闻稿和网路广播。註:公司简介部分所包含的所有财务资料均已标准化为美元。对于以其他货币报告的公司,数据已使用相应年份的相关汇率转换为美元。
一手研究 Insight Partners 每年都会与行业利益相关者和专家进行大量的一手调查,以验证其资料分析,并获得宝贵的见解。这些研究访谈旨在:
验证并完善二手资料研究的结果。提升分析团队的专业知识和市场理解。深入了解市场规模、趋势、成长模式、竞争动态和未来前景。一手资料研究透过电子邮件互动和电话访谈进行,涵盖不同地区的各种市场、类别、细分市场和次细分市场。参与者通常包括:
产业利害关係人:副总裁、业务发展经理、市场情报经理和国家销售经理外部专家:估值专家、研究分析师和具有行业专业知识的关键意见领袖
The North America Laser-Assisted ENT Surgery Market size is expected to reach US$ 2,45,109.60 thousand by 2031 from US$ 1,20,527.14 thousand in 2023. The market is estimated to record a CAGR of 9.3% from 2023 to 2031.
Executive Summary and North America Laser-Assisted ENT Surgery Market Analysis:
The rising prevalence of ENT disorders, such as chronic sinusitis, is propelling the demand for effective treatment options in Canada. For instance, according to Canadian Family Physician, rhinosinusitis is common, afflicting approximately 1 in 8 adults in Canada. Population aging and increasing awareness regarding ENT health issues benefit the laser-assisted ENT surgery market in the country.
North America Laser-Assisted ENT Surgery Market Segmentation Analysis:
Key segments that contributed to the derivation of the laser-assisted ENT surgery market analysis are laser type, surgery type, and end user.
By laser type, the laser-assisted ENT surgery market is segmented into CO2 laser, Nd:YAG laser, diode laser, blue laser, KTP laser, argon laser, and other laser types. The CO2 laser held the largest share of the market in 2023.
In terms of surgery type, the laser-assisted ENT surgery market is divided into laser laryngeal surgery, laser endoscopic sinus surgery (less), laser-assisted uvulopalatoplasty (LAUP), laser-assisted stapedotomy, laser-assisted tonsillectomy and adenoidectomy, laser turbinate reduction, transoral laser microsurgery (TLM), nasal surgery, and other surgery types. The laser-assisted tonsillectomy and adenoidectomy segment held the largest share of the market in 2023.
Based on end user, the laser-assisted ENT surgery market is categorized into hospitals and specialty clinics, physician office, and other end-users. The hospitals and specialty clinics segment held the largest share of the market in 2023.
North America Laser-Assisted ENT Surgery Market Outlook
Conditions such as chronic sinusitis, sleep apnea, hearing loss, and various tumors of the head and neck are becoming more common, necessitating advanced surgical interventions. Laser-assisted surgeries offer a compelling solution due to their minimally invasive nature, which aligns with the growing preference among patients for procedures that promise quick recovery times and less postoperative discomfort. According to an article published in Rhinology in 2024, the prevalence range of chronic rhinosinusitis is 5-12%; from this, 20% have nasal polyps worldwide.
As the global population ages, the demand for effective and innovative treatment options for ENT (i.e., ear, nose, and throat) disorders surges in tandem. Also, environmental factors further worsen ENT-related conditions. According to the National Council on Aging, Inc., hearing loss affects about 60.7 million Americans aged 12 and older. About 15.5% (44.1 million) of American adults aged 20 and older have hearing loss. Further, the increasing prevalence of ENT disorders is accompanied by a heightened awareness of the importance of early diagnosis and treatment. As patients are more informed than ever about their health options, they willingly seek advanced therapies, thereby fundamentally reshaping the landscape of otolaryngological treatments. This trend is bolstered by technological advancements in diagnostic tools, which facilitate earlier detection of ENT conditions. Thus, as soon as patients are diagnosed, the likelihood of requiring surgical intervention increases, propelling the number of laser-assisted surgeries.
North America Laser-Assisted ENT Surgery Market Country Insights
Based on country, the North America laser-assisted ENT surgery market comprises the US, Canada, and Mexico. The US held the largest share in 2023.
The Sylvester Comprehensive Cancer Center was the first in the US to use the 445-nm blue laser for early glottic cancer treatment, the most common type of laryngeal cancer. There are approximately 2,000 otologists in the US. Many of them use 532-nm laser systems to perform stapedectomy and stapedotomy procedures to correct certain types of hearing loss. In the US, several FDA-approved ENT laser devices, notably CO2 laser devices, are widely used in procedures such as adenoidectomy and laryngeal surgery due to their precision and minimal thermal damage to surrounding tissues. Further, Nd: YAG laser systems are diode lasers that are commonly used to treat conditions such as nasal obstruction and perform laser-assisted uvulopalatoplasty. The US Food and Drug Administration has also cleared BIOLASE's EPIC 10 soft-tissue lasers for ENT surgical procedures. As more healthcare facilities adopt FDA-approved lasers, patient outcomes are likely to improve through reduced recovery times and enhanced procedural accuracy. The FDA's approval of these devices is crucial, ensuring they meet stringent safety and efficacy standards and fostering confidence among healthcare providers and patients.
North America Laser-Assisted ENT Surgery Market Company Profiles
Some of the key players operating in the market include biolitec AG (Biolitec); Iridex Corporation; Medency; Dimed Laser Technology Co., Ltd.; intros Medical Laser GmbH; ARC Laser GmbH; LightScalpel; GIGAAMEDICAL; INTERmedic ARFRAN; Limmer Laser GmbH; Qolight Medical Laser; and Sisram Medical Ltd., among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
North America Laser-Assisted ENT Surgery Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise